Navigation Links
BYDUREON™ RECEIVES MARKETING AUTHORIZATION IN EUROPE
Date:6/21/2011

een the industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Mass., Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.

This press release contains forward-looking statements about Amylin, Lilly and Alkermes. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that BYDUREON may not be approved by the FDA as soon as anticipated or at all; the companies' response to the FDA's complete response letter may not be submitted in a timely manner and/or the information provided in such response may not satisfy the FDA; the FDA may request additional information prior to approval; BYETTA and/or the approval of BYDUREON and the revenues generated from these products may be affected by competition; unexpected new data; safety and technical issues; clinical trials not being completed in a timely manner, not confirming previous results, not being predictive of real world use or not achieving the intended clinical endpoints
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. BYDUREON™ Recommended for Approval in Europe
2. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
3. BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010
4. Access Pharmaceuticals Receives Letter of Acceptance For MuGard Filing From SFDA of China
5. Omnicells OmniRx Automated Medication Dispensing System Receives 2011 Best in KLAS Award
6. EndoSphere Inc. Receives Patent for Obesity Treatment
7. Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease
8. TrueBeam™ System for Non-Invasive Image-Guided Cancer Treatment Receives Shonin Approval
9. Ventana Medical Systems, Inc. Receives FDA Approval for the First Fully Automated Diagnostic Assay for HER2 Gene Status Determination in Breast Cancer Patients
10. Mindray Medical Receives the 2011 Medical Device Excellence Award for its V Series Patient Monitoring System
11. MGT Capital Investments Receives NYSE Amex Listing Deficiency Notification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)...  Syneron Medical Ltd. (NASDAQ: ELOS ), a leading ... three month period ended June 30, 2015. ... Highlights: , Revenue of $73.5 million, up ... American product sales grew 45% year-over-year. , International sales ... product growth in the EMEA region and 25% product growth ...
(Date:8/3/2015)... 3, 2015  Luminex Corporation (NASDAQ: LMNX ) ... June 30, 2015.  Financial and operating highlights for the ... quarter 2015 revenue by 6 percent to $58.9 million, ... second quarter 2015 assay revenue by 22 percent to ... 2014. , Increased Q2 2015 royalty revenue by ...
(Date:8/3/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ), the ... quarter ended June 30, 2015. All comparisons, unless otherwise noted, ... Second Quarter 2015 Highlights include: , Revenue ... , Total prescriptions dispensed of 234,000, an increase of ... , Adjusted EBITDA of $22.7 million, an increase of 287% ...
Breaking Medicine Technology:Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17Luminex Corporation Reports Record 2nd Quarter 2015 Results 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 3Luminex Corporation Reports Record 2nd Quarter 2015 Results 4Luminex Corporation Reports Record 2nd Quarter 2015 Results 5Luminex Corporation Reports Record 2nd Quarter 2015 Results 6Luminex Corporation Reports Record 2nd Quarter 2015 Results 7Luminex Corporation Reports Record 2nd Quarter 2015 Results 8Luminex Corporation Reports Record 2nd Quarter 2015 Results 9Luminex Corporation Reports Record 2nd Quarter 2015 Results 10Luminex Corporation Reports Record 2nd Quarter 2015 Results 11Luminex Corporation Reports Record 2nd Quarter 2015 Results 12Luminex Corporation Reports Record 2nd Quarter 2015 Results 13Luminex Corporation Reports Record 2nd Quarter 2015 Results 14Luminex Corporation Reports Record 2nd Quarter 2015 Results 15Luminex Corporation Reports Record 2nd Quarter 2015 Results 16Diplomat Announces 2nd Quarter 2015 Financial Results 2Diplomat Announces 2nd Quarter 2015 Financial Results 3Diplomat Announces 2nd Quarter 2015 Financial Results 4Diplomat Announces 2nd Quarter 2015 Financial Results 5
... American Association of,Health Freedom and the International ... the Baromedical Research,Institute and Louisiana State University ... successful treatment of chronic traumatic brain injury,(TBI). ... Oct 12;1174:120-9),are purportedly the first-ever demonstration of ...
... Oct. 10 Face,transplants, once on the fringe ... new estimates that suggest the risk of tissue,rejection ... a recent,review in Plastic and Reconstructive Surgery(R) (PRS), ... Plastic Surgeons (ASPS)., "We can only know ...
Cached Medicine Technology:Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury 2Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests 2
(Date:8/4/2015)... ... August 04, 2015 , ... Seedstock’s ... for Nov. 3 – 4, 2015, at UC San Diego, will explore innovations ... improve food access, and manage resources efficiently against the dueling backdrop of a ...
(Date:8/4/2015)... , ... August 04, 2015 , ... 24/7 Care ... Los Angeles, Riverside, and San Bernardino, today announced that the U.S. Department of Veteran’s ... that 24/7 Care At Home’s agency is well on the path to meeting the ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... design, product packaging, and fulfillment services, joined over 200 other Long Island-based corporations ... held on Tuesday, July 28th at Jones Beach State Park in Wantagh, New ...
(Date:8/4/2015)... ATLANTA & LAS VEGAS (PRWEB) , ... August 04, 2015 , ... ... released the pitch schedule for vendor participating in The ISE® Lions’ Den and Jungle ... and Spa at Aria in Las Vegas. , During the event, eight emerging security ...
(Date:8/4/2015)... ... August 04, 2015 , ... MedicaSoft ... Office of the National Coordinator for Health Information Technology (ONC-HIT) 2014 Edition ... highest quality personal health record and patient portal solution to healthcare providers ...
Breaking Medicine News(10 mins):Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3
... the most dreadful kind of Dementia, where there is degeneration ... awaited miracle cure round the corner. A vaccine made ... in mice, which is characteristic of Alzheimer’s. Latest reports say ... human testing ,the first stages of which have been successful ...
... loved one die. More tragic is when the decision on ... thread. Most patients of road traffic accidents, severe stokes, head ... where they live technically only on life support systems. The ... to give consent to the medical staff attending on these ...
... open show of support to Alternative Medicine, Britain's Prince Charles ... million) to fund a five-year research program into the effects ... taking notice of holistic medicine and Prince Charles’s support to ... in the arm for these crusaders of integrated medicine. ...
... word to make people sit up and take notice in health ... mention of the word is enough to bolster people to sit ... heard and said about the disease? Or should we use our ... Should we believe all that is written about and said about ...
... the dosages of drugs are determined? How drugs are being ... What happens if the dosages are unwittingly missed? Or worse ... happens? Who answers these questions? In a shocking revelation, ... instances about a third of medication errors that result in ...
... supplements have been identified as having a possible ... so by reducing the level of an amino acid called ... the culprit, increasing clot formation in blood vessels. ,Ongoing ... about the superior benefits of these vitamin supplements over a ...
Cached Medicine News:Health News:Brain death – How to cope with it 2Health News:The Cancer Rumour mill working over time 2
... just about everything imaginable that might have to ... is designed for long term storage under archival ... over metal systems is overlooked, while the natural ... of desiccator and insulator, providing an environment that ...
A prepared Microscope Slide Cataloging and Storage System....
... Our moisture resistant, plastic covered ... high, each supporting up to 500 ... weight. Each box accommodates 2000 slides ... your varied storage requirements. Come unassembled ...
Shandon Plastic Slide Boxes...
Medicine Products: